Impel Pharmaceuticals
Earnings Date & Report
Last updated:
Impel Pharmaceuticals’s last earnings date was on 13 Nov 2023. It reported its quarterly earnings per share (EPS) reaching -$0.58. The company’s quarterly earnings increased by 62.98% to 5.02M US dollars compared to the same quarter of the previous year. Over the last year, Impel Pharmaceuticals’s earnings per share have grown by 55.6%.
Impel Pharmaceuticals stock Earnings report, Estimates & History
| 2021-06-07 | 0.93 | 0.54 |
|---|---|---|
| 2021-08-16 | -0.59 | -0.79 |
| 2021-11-15 | -0.82 | -1.24 |
| 2022-03-24 | -0.86 | -1.07 |
| 2022-05-16 | -1.08 | -1.17 |
| 2022-08-15 | -1.13 | -1.09 |
| 2022-11-14 | -0.87 | -1.31 |
| 2023-03-24 | -1.04 | -0.97 |
| 2023-05-12 | 0.9 | -1.27 |
| 2023-08-18 | -0.65 | -0.31 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Impel Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 13 Nov 2023 | N/A | N/A | -$0.58 | N/A | 5.02M | |
| 18 Aug 2023 | Beat | -$0.65 | -$0.31 | N/A | 6.58M | |
| 12 May 2023 | Missed | $0.9 | -$1.27 | N/A | 4.37M | Earnings Call Transcript |
| 24 Mar 2023 | Beat | -$1.04 | -$0.97 | N/A | 5.00M | Earnings Call Transcript |
| 14 Nov 2022 | Missed | -$0.87 | -$1.31 | N/A | 3.08M | Earnings Call Transcript |
| 15 Aug 2022 | Beat | -$1.13 | -$1.09 | N/A | 2.80M | Earnings Call Transcript |
| 6 Jun 2022 | N/A | -$1.08 | N/A | 1.8M | N/A | |
| 16 May 2022 | Missed | -$1.08 | -$1.17 | 1.8M | 1.75M | Earnings Call Transcript |
| 24 Mar 2022 | Missed | -$0.86 | -$1.07 | 1.66M | 577K | Earnings Call Transcript |
| 15 Nov 2021 | Missed | -$0.82 | -$1.24 | 8M | 91K | Earnings Call Transcript |
| 16 Aug 2021 | Missed | -$0.59 | -$0.79 | N/A | N/A | Earnings Call Transcript |
| 7 Jun 2021 | Missed | $0.93 | $0.54 | N/A | N/A | |
| 31 Dec 2020 | N/A | N/A | -$1.07 | N/A | N/A | |
| 30 Sep 2020 | N/A | N/A | -$0.69 | N/A | N/A | |
| 30 Jun 2020 | N/A | N/A | -$0.98 | N/A | N/A | |
| 31 Mar 2020 | N/A | N/A | -$0.74 | N/A | N/A | |
Impel Pharmaceuticals Earnings report FAQs
When is Impel Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Impel Pharmaceuticals's earnings date was on 14 Nov 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.